News
AstraZeneca reports Trixeo Aerosphere approved in EU for COPD maintenance
AstraZeneca’s Trixeo Aerosphere has been approved in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid (ICS)...
News
SpiceXpress strengthens pharma cold chain capabilities with Om partnership
SpiceXpress, the cargo division of India-based carrier SpiceJet, has partnered with Om Logistics to strengthen its capabilities to transport temperature-sensitive Covid-19 vaccines.
The carrier said the partnership aims to provide a “speedy, seamless and reliable solution” for the movement of...
Clinical Trials
Sanofi, GSK COVID-19 vaccine rollout delayed on low immune response in older adults
Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Phase 1/2 study interim results showed an immune response comparable to patients who recovered from COVID-19 in adults...
News
CHMP recommends approval of Plavix with aspirin in adults for certain types of strokes
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an additional indication for Plavix® (clopidogrel) in adult patients with high-risk transient ischemic attack (TIA) or minor ischemic stroke (IS). This...
News
Astrazeneca To Test Combining COVID-19 Vaccine With Russian Shot
Britain's AstraZeneca said on Friday it would investigate combining its experimental COVID-19 vaccine with Russia's Sputnik V vaccine candidate, a move Russian scientists have suggested could sharply boost efficacy.
The developers of Sputnik V suggested on Twitter last month that...
News
Covaxin likely to be available in first quarter of 2021: Bharat Biotech
As companies across the globe are speeding up to bring an effective COVID vaccine, Bharat Biotech’s Joint Managing Director Suchitra Ella hinted that India’s indigenous Covaxin in the country is likely to be available in the first quarter of...
News
Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic for Adult Patients with Newly Diagnosed and Previously Treated Myelofibrosis
Bristol Myers Squibb announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Inrebic® (fedratinib) for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adult patients with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















